Treatment of reflux in infants: clinical results with Reflucalm Gastroesophageal reflux in infants is a common condition characterized by frequent regurgitation, inconsolable crying, sleep disturbances, and feeding difficulties. When persistent, these symptoms can cause significant stress for parents and impact the infant’s overall well-being. Reflucalm is a medical device specifically designed for the treatment of…
A natural alternative for a widespread condition Gastroesophageal reflux is a very common condition that affects millions of people worldwide, causing symptoms such as heartburn, acid regurgitation, bloating, and epigastric pain. Proton pump inhibitors are the most common treatment. However, using them for a long time can cause serious side effects. These side effects include…
Medical device with Hyaluronic Acid, Magnesium Alginate, and Myrrh: intense and lasting relief against gastroesophageal reflux Starting from 2025, we have officially registered our Class IIa medical device for the treatment of severe gastroesophageal reflux disease (GERD) with the Ministry of Health and Prevention of the United Arab Emirates (UAE). Severe GERD: a significant impact…
Quince: Health, Antioxidant, and Cardioprotective Benefits The quince (Cydonia oblonga) is a fruit native to Western Asia, particularly in areas corresponding to modern-day Turkey and Iran. This fruit, cultivated and cherished for centuries, is rich in essential nutrients beneficial for human health. Notable among these are vitamin C, which helps strengthen the immune system; potassium,…
Registration of Class IIa Medical Device for Gastroesophageal Reflux at the Department of Health in Hanoi, Vietnam The Department of Health in Hanoi, Vietnam officially registered our Class IIa medical device. Additionally, it’s important to note that the device holds an MDD certificate extension. The device is an oral emulsion composed of key actives: low…
Extension of MDD Certificate for Our Medical Devices for the Treatment of Gastroesophageal Reflux Disease (GERD) Based on Alginates The MDR regulation, effective from May 2017 and applicable from May 2021, governs medical devices in Europe. Deadline extensions allow the marketing of devices compliant with the Medical Devices Directive (MDD) until December 31, 2027, for…